Skip to main content

Table 2 Comparison of participants in viral load sub-study in 2012 -13 with other participants in Jinja Cohort

From: Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda

Variable

Total N

Participants in VL sub-study

p value

No (N = 2540)

Yes (N = 805)

N

(%)

N

(%)

Clinical outcomes

3345

    

<0.001

 Survived and retained in care

 

1525

(60)

797

(99)

 

 Dead

 

577

(23)

0

(0)

 

 Lost to follow-up

 

283

(11)

2

(0)

 

 Transferred out

 

155

(6)

6

(1)

 

Gender

3345

    

<0.001

 Female

 

1757

(69)

623

(77)

 

 Male

 

783

(31)

182

(23)

 

CD4 at ART initiation

3099

    

<0.001

 <50

 

429

(18)

55

(7)

 

 50–199

 

958

(42)

278

(35)

 

 ≥200

 

915

(40)

464

(58)

 

Hemoglobin count of participant at ARV initiation or clinical visit

2222

    

0.025

 <8

 

71

(4)

13

(2)

 

 ≥8

 

1574

(96)

564

(98)

 

WHO stage

2829

    

0.749

 Stage 1

 

40

(2)

10

(1)

 

 Stage 2

 

992

(47)

359

(49)

 

 Stage 3

 

913

(44)

318

(43)

 

 Stage 4

 

147

(7)

50

(7)

 

Occupation

2920

    

0.384

 Casual labourer

 

202

(9)

59

(9)

 

 Paid employee

 

187

(8)

48

(7)

 

 Peasant

 

940

(41)

268

(41)

 

 Vendor/business person

 

321

(14)

98

15)

 

 Other

 

246

(11)

61

(9)

 

 None

 

401

(17)

89

(14)

 

Education level

2920

    

0.092

 None/preprimary/other

 

382

(17)

100

(16)

 

 Some primary

 

1294

(56)

324

(52)

 

 Some secondary

 

545

(24)

174

(28)

 

 Higher education

 

75

(3)

26

(4)

 

First ARV regimen

3076

    

0.003

 Efavirenz/Zidovudine/Lamivudine

 

233

(10)

90

(11)

 

 Efavirenz/Stavudine/Lamivudine

 

136

(10)

64

(8)

 

 Nevirapine/Stavudine/Lamivudine

 

688

(30)

262

(33)

 

 Nevirapine/Zidovudine/Lamivudine

 

1034

(45)

327

(42)

 

 Other ARV regimen

 

198

(7)

44

(6)

 

Year of ART initiation

3345

2006

(2006–2008)

2006

(2005–2007)

<0.001

  1. N = 3345 Jinja cohort participants